ArticleInternational ophthalmology2025
The patient-based socioeconomic burden of glaucoma care in nigeria: a scoping review.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlaucoma remains the leading cause of irreversible blindness worldwide, with Nigeria facing a substantial public health burden that affects approximately 1.1-1.4 million individuals, with many that remain undiagnosed. Socioeconomic factors such as income, education, and access to healthcare services play a crucial role in the management and treatment outcomes of glaucoma in diagnosed individuals.
objectivesThis scoping review aims to investigate the socioeconomic burden of glaucoma care in Nigeria and to determine potential solutions to improve access to diagnosis and treatment of glaucoma. METHODOLOGY: A comprehensive literature review was conducted to assess the socioeconomic burden of Glaucoma care (direct and indirect costs) in Nigeria. Five databases, namely PubMed, Scopus, Web of Science, African Journals Online (AJOL), and Nigerian Journal Online (NJOL), were searched for peer-reviewed articles published within the last 15 years, including grey literature, policy documents, the WHO Global Health Expenditure Database, World Bank Health Statistics, government, and NGO reports were also included. PRISMA-ScR guidelines were followed to ensure transparency. The JBI checklist was used to examine the quality and bias of the included studies. A thematic analysis was utilized in synthesizing the findings, and narrative synthesis was used in presenting the findings.
resultsFrom the initial search, only seven (7) articles met the inclusion criteria. Six (5) were quantitative, and two (2) were qualitative studies. Regarding geo-political distribution, three (3) articles were conducted in the South-South, two (2) in the North-West, one (1) combined North-Central and North-West locations, and one (1) was a national survey. Seven (7) studies examined patients with glaucoma, and one (1) study used physicians as a study population. It was demonstrated that the high cost of glaucoma care disproportionately affected low socioeconomic and uninsured populations, with significant barriers to timely diagnosis and treatment.
conclusionThe review highlighted the burden of glaucoma care on the poor in Nigeria. Therefore, there is an urgent need to improve access for this group through integration policies, such as the national health insurance scheme, as well as subsidized costs for diagnosis, medications, treatments, and surgeries. Comprehensive policy interventions may be essential to sustain glaucoma care initiatives in Nigeria, improve treatment adherence, and ultimately reduce the socioeconomic burden of this debilitating public health condition.
Indexed as
Identifiers
41117979What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.